We understand and support the need for increased disclosure of clinical trial data, and we continue to work with the Association of the British Pharmaceutical Industry (ABPI) on this important topic to ensure that any emerging regulations will result in benefits for everyone engaged in clinical research and patient care.
Since the publication of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Joint Position on the Disclosure of Clinical Trial Information, Napp has complied with the requirements to register and publish the outcomes of all trials that we have sponsored and that have been carried out in patients. Where possible, we publish data through peer-reviewed journals, but if this is not possible, we will share the data through a clinical trials registry, such as www.clinicaltrials.gov, www.clinicaltrialsregister.eu or here on our website.
Further information on Napp sponsored studies
If you are searching for clinical studies involving our medicines, they may be available by searching for the medicine name on www.clinicaltrials.gov, or you can contact our Medical Information Team for advice.